Overall rank by patents
#49,006
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 13 technology areas, active 2022–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS).
The verdict
Nextchem holds 5 US patents across 13 technology areas, rank #49,006 of 50,000 tracked assignees.
Nextchem S.p.a. has been granted 5 US utility patents between 2022 and 2023, placing Nextchem S.p.a. at rank #49,006 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS). As a Foreign Corporation, Nextchem S.p.a. is one of the more focused assignees in the PatentsView dataset. By volume, Nextchem sits between Newteq Holding B.v. (5 patents, rank #49,002) and NF Co.,ltd (5 patents, rank #49,010) - the closest US assignees by grant volume. The composite Innovation Score of 49.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2023, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Nextchem S.p.a.'s 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nextchem S.p.a. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NEWTEQ HOLDING B.V.
5 patents
NEX MEDICAL ANTISEPTICS S.R.L.
5 patents
NEXGEN COMPOSITES LLC
5 patents
NEXO
5 patents
NEXTPAT LIMITED
5 patents
NEXTSHIFT ROBOTICS, INC.
5 patents
NEXUS HEALTH RESOURCES, INC.
5 patents
NF CO.,Ltd
5 patents
NEXTCHEM S.P.A.
5 patents
What this shows Nextchem holds 5 patents at rank #49,006, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,006 in granted patent volume.
Other assignees with the most granted patents in Nextchem's primary technology class.
Nextchem's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 3 | 60.0% |
| 2023 | 2 | 40.0% |
Top 13 of 13 technology areas
Overall rank by patents
#49,006
Across all tracked assignees
49.3 out of 100
How to use this portfolio
Nextchem's 5 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.